Nausea is also common as your body begins to adjust, and some people may experience vomiting, diarrhea, or abdominal pain soon after the first dose
Kaushik S, Rodriguez-Navarro Jose A, Arias E, Kiffin R, Sahu S, Schwartz Gary J, Cuervo Ana M, Singh R
Results: Prescribing of GLP-1 RA medications, particularly semaglutides, increased notably over the years, whereas dulaglutide, liraglutide, and exenatide use declined
Activation of Glucagon-like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses
If you experience any of these symptoms, do not hesitate to contact your GP or NHS 111 for guidance
Patients on ACA exchange plans whose BMI is below 40 are generally excluded from new Wegovy weight-loss coverage